International Journal of Clinical Pharmacy

, Volume 35, Issue 4, pp 510–512 | Cite as

A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment

  • Pablo Moura  SantosEmail author
  • Lúcia Noblat
  • Álvaro A. Cruz


Asthma is a chronic inflammatory disorder of the airways that is characterized by recurrent symptoms associated with airflow limitation and by bronchial hyper-responsiveness. Free asthma treatment has been guaranteed in Brazil since 2003, notably after the Brazilian government decided to support drugs for the most serious forms of the disease. The asthma treatment access policy in Brazil offers a new opportunity for pharmacists to work closely with patients, and for caregivers and health care teams to promote educational activities and patient counselling about asthma. Pharmacists have an important role in the management of drug therapy within the health care team. Pharmacists should be prepared to engage with the latest concept of health care delivery proposed for Brazilian Unified Health System. These are centred on forming health care networks and strengthening multidisciplinary teams to integrate all professionals who are in charge of patient care.


Asthma Brazil Drug policy Pharmacists Public health 


Conflicts of interest

The authors report no conflicts of interests.


  1. 1.
    World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007.Google Scholar
  2. 2.
    Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.PubMedCrossRefGoogle Scholar
  3. 3.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMedGoogle Scholar
  4. 4.
    Ministério da Saúde (Brasil). Portaria no. 1.146 de 1 de junho de 2012. Altera e acresce dispositivos à portaria n 971/GM/MS, de 17 de maio de 2012, para ampliar a cobertura da gratuidade no âmbito do Programa Farmácia Popular do Brasil. Diário Oficial da União 2012; 1:107. [Brazilian Ministry of Health. Decree no. 1146 of 1 June 2012. Amends and adds provisions to the Decree no. 971/GM/MS of May 17, 2012, to expand the coverage of gratuity under the Popular Pharmacy Program in Brazil. Official Gazette 2012; 1:107].Google Scholar
  5. 5.
    Ministério da Saúde (Brasil). Brasília—DF. c2012. Available at: Accessed 22 May 2012). [Ministry of Health (Brazil). Brasilia—DF].
  6. 6.
    Ministério da Saúde (Brasil). Portaria no. 1.318 de 23 de julho de 2002. Diário Oficial da União. 2002;1:68. [Ministry of Health. Decree no. 1318 of 23 July 2002. Official Gazette 2002; 1:68].Google Scholar
  7. 7.
    Ministério da Saúde (Brasil). Portaria no. 2.577 de 27 de outubro de 2006. Diário Oficial da União. 2006;1:44. [Ministry of Health. Decree no. 2577, 27 October 2006. Official Gazette 2006, 1:44].Google Scholar
  8. 8.
    Ministério da Saúde (Brasil). Portaria no. 2.084 de 26 de outubro de 2005. Diário Oficial da União. 2006;1:44. [Ministry of Health Decree no. 2084 of 26 October 2005. Official Gazette 2006, 1:44].Google Scholar
  9. 9.
    Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o manejo da asma. J Bras Pneumol. 2012; 38 Suppl 1: S1-S46. [Guidelines of the Brazilian Thoracic Association for the Treatment of Asthma].Google Scholar
  10. 10.
    Cerci Neto A, Ferreira Filho OF, Bueno T, et al. Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil. J Bras Pneumol. 2008;34(9):639–45.PubMedCrossRefGoogle Scholar
  11. 11.
    Franco R, Nascimento HF, Cruz AA, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64:478–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 1, Art. No. CD000336. doi:  10.1002/14651858.CD000336.pub4.
  13. 13.
    Santos DB, Cruz AA, Simões SM, et al. Pattern of asthma medication use among children from a large urban center in Brazil. Eur J Clin Pharmacol. 2012;68(1):73–82.PubMedCrossRefGoogle Scholar
  14. 14.
    Santos DO, Martins MC, Cipriano SL, et al. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol. 2010;36(1):14–22.CrossRefGoogle Scholar
  15. 15.
    Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician’s Guide. 2nd ed. The McGraw-Hill, c2004. ISBN 0-07-136259-2.Google Scholar
  16. 16.
    Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Pablo Moura  Santos
    • 1
    • 3
    Email author
  • Lúcia Noblat
    • 2
  • Álvaro A. Cruz
    • 3
  1. 1.Pharmacy Unit, Professor Edgard Santos University HospitalFederal University of BahiaSalvadorBrazil
  2. 2.School of PharmacyFederal University of BahiaSalvadorBrazil
  3. 3.Program for the Control of Asthma (ProAR) and Center of Excellence in Asthma, School of MedicineFederal University of BahiaSalvadorBrazil

Personalised recommendations